trending Market Intelligence /marketintelligence/en/news-insights/trending/e14sjxzrvlxzrycvzzzgwa2 content esgSubNav
In This List

UK's GlaxoSmithKline to cut 650 jobs in US

Blog

Insight Weekly: Unease roils markets; US likely to slip into recession; firms' cash ratios fall

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch


UK's GlaxoSmithKline to cut 650 jobs in US

U.K.-based drugmaker GlaxoSmithKline PLC will slash about 650 jobs in the U.S. as part of a previously announced restructuring, Reuters reported, citing a company spokeswoman.

The cuts will include 450 sales positions and about 100 back office jobs from each of the Philadelphia and at Research Triangle Park, N.C., locations. The company has about 15,000 employees in the U.S.

Savings generated will go toward research and development and commercial support of new products, spokeswoman Mary Anne Rhyne said.

CEO Emma Walmsley revealed a restructuring program in July that will lead to projected cost savings of £400 million a year by 2021.